Biokinetic and PBPK modelling to support the rotenone and strobilurin read across case studies (CS4) 2019 年 9 月 4 日 By webdev
Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues 2019 年 9 月 4 日 By webdev
Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human 2019 年 9 月 4 日 By webdev
Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations 2019 年 9 月 3 日 By webdev
Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. 2019 年 9 月 3 日 By webdev
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach 2019 年 9 月 3 日 By webdev
Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug 2019 年 9 月 3 日 By webdev
Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework 2019 年 9 月 3 日 By webdev
Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy 2019 年 9 月 3 日 By webdev